F.D.A. Experts Will Vote on Safety of a Cure for Sickle Cell Disease
The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.
Source: NYT Health - Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Food and Drug Administration Crispr (DNA) Vertex Pharmaceuticals Inc Genetic Engineering Drugs (Pharmaceuticals) Therapy and Rehabilitation CRISPR Therapeutics Source Type: news
More News: Anemia | Food and Drug Administration (FDA) | Genetics | Health | Rehabilitation | Sickle Cell Anemia